Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China flag China · Delayed Price · Currency is CNY
36.60
-0.13 (-0.35%)
At close: Sep 4, 2026

SHA:688765 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-160.81-151.37-186.96-143.58-134.04-53.35
Depreciation & Amortization
61.4461.4447.8212.9210.0410.11
Other Amortization
0.40.40.01---
Loss (Gain) From Sale of Assets
1.281.28-1.01-0.3311.27-2.08
Asset Writedown & Restructuring Costs
0.480.481.111.3-0.06
Provision & Write-off of Bad Debts
000.01-0.0500.01
Other Operating Activities
-55.545.180.990.340.81.13
Change in Accounts Receivable
-9.95-9.9518.19-7.88-21.29-2.36
Change in Inventory
-14.29-14.29-10.06-13.150.86-1.1
Change in Accounts Payable
32.232.2-16.2660.8226.57-2.42
Change in Other Net Operating Assets
21.121.123.3223.217.8214.81
Operating Cash Flow
-123.7-53.53-122.85-66.4-87.97-35.18
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Capital Expenditures
-345.93-166.84-101.59-358.29-175.47-1.66
Sale of Property, Plant & Equipment
-40.48-0.68--
Investing Cash Flow
-345.93-126.37-101.59-357.61-175.47-1.66

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Long-Term Debt Issued
-133.5577.9830.49.912.6
Total Debt Issued
442.56133.5577.9830.49.912.6
Long-Term Debt Repaid
--23.5-1-16.27-20.29-14.23
Lease Payments
-----0.39-
Total Debt Repaid
-25.81-23.5-1-16.27-20.29-14.23
Net Debt Issued (Repaid)
416.75110.0576.9814.13-10.39-1.63
Issuance of Common Stock
---556.32367.31176.38
Common Dividends Paid
-11.65-4.63-1.18-0.74-0.66-1.07
Other Financing Activities
-8.15-1.15-3.17-1.58--
Financing Cash Flow
396.95104.2872.64568.12356.26173.69

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Foreign Exchange Rate Adjustments
-0.030.060.220.04-0.07-0.5
Net Cash Flow
-72.71-75.57-151.58144.1592.75136.34

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Free Cash Flow
-469.63-220.38-224.45-424.7-263.44-36.85
Free Cash Flow Growth
------
Free Cash Flow Margin
-2008.10%-873.96%-925.01%-3169.45%-1032.38%-170.86%
Free Cash Flow Per Share
-1.74-0.81-0.84-1.63-1.22-0.74
Levered Free Cash Flow
--121.68-222.43-387.25-136.64-24.29
Unlevered Free Cash Flow
--118.49-222.01-387.11-136.31-23.68
Free Cash Flow After Leases
-469.63-220.38-224.45-424.7-263.84-36.85

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash Income Tax Paid
--1.59-27.87-44.15-1.72-0.44
Change in Working Capital
29.0529.0515.1962.9923.958.94